首页> 外文期刊>Oncology letters >Effects of microRNA-20a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN/PI3K/AKT signaling pathway
【24h】

Effects of microRNA-20a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN/PI3K/AKT signaling pathway

机译:MicroRNA-20A对通过PTEN / PI3K / AKT信号通路的多发性骨髓瘤的增殖,迁移和凋亡的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Multiple myeloma (MM) is a heterogeneous disease with a poor prognosis. Circulating microRNAs (miRNAs) have shown potential as non-invasive prognostic biomarkers for heterogeneous diseases. miR-20a has been shown involved in various human cancers, and the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B (PTEN/P13K/Akt) signaling pathway plays a key role in cell proliferation, migration and apoptosis. Here, we investigated the effect of miR-20a on the PTEN/PI3K/Akt signaling pathway during MM cell proliferation, migration and apoptosis. Reverse transcription quantitative polymerase chain reaction was applied to detect miR-20a expression in plasma from 30 MM patients and MM cell lines. CCK-8 assays, Transwell assays, Annexin V/PI double-staining and western blotting were performed to examine the protein expressions of PTEN, PI3K and Akt during cellullar proliferation, migration, cycling, and apoptosis. Significant upregulation of miR-20a and deregulation of PTEN were observed in MM cells. We also identified PTEN as a downstream target gene of miR-20a, which bound to the 3'-untranslated region of PTEN. Overexpression of miR-20a was associated with decreased PTEN expression, and treatment with miR-20a inhibitors decreased cell proliferation, migration and clonogenicity and reduced the protein expressions of PI3K and p-Akt but increased PTEN protein expression compared with blank and negative control groups. Taken together, these results showed that inhibition of miR-20a suppresses MM progression by modulating the PTEN/PI3K/Akt signaling pathway. These findings suggest that miR-20a may be a novel molecular therapeutic target for the treatment of MM.
机译:多发性骨髓瘤(mm)是一种异质疾病,预后差。循环的microRNA(miRNA)显示出潜在的非侵入性预后生物标志物,用于异质疾病。已经显示在各种人类癌症中涉及MIR-20A,并且磷酸酶和三素同源物/磷酸膦酸3-激酶/蛋白激酶B(PTEN / P13K / AKT)信号通路在细胞增殖,迁移和凋亡中起着关键作用。在这里,我们研究了MM细胞增殖,迁移和细胞凋亡期间MIR-20A对PTEN / PI3K / AKT信号通路的影响。逆转录定量聚合酶链反应用于检测来自30mm患者和MM细胞系的血浆中的miR-20a表达。 CCK-8测定,进行Transwell测定,吞咽δV/ PI双染料和蛋白质印迹,以检查PTEN,PI3K和AKT期间PTEN,迁移,循环和细胞凋亡的蛋白质表达。在MM细胞中观察到MIR-20a的显着上调和PTEN的放管。我们还将PTEN鉴定为miR-20a的下游靶基因,其与PTEN的3'-未翻译区域结合。 miR-20a的过表达与PTEN表达降低有关,并且用miR-20a抑制剂治疗降低了细胞增殖,迁移和克隆因,并降低了PI3k和p-akt的蛋白质表达,但与坯料和阴性对照组相比增加了PTEN蛋白表达。总之,这些结果表明,通过调节PTEN / PI3K / AKT信号通路来抑制miR-20a抑制MM进展。这些发现表明miR-20a可以是用于治疗mm的新型分子治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号